$SKYE 8-K SEC Filings

Filed On	Filing
11 Sep 2026	8-K: Termination of a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more On September 8, 2026, in connection with the resignation of John P. Sharp as Chief Financial Officer and principal financial and accounting officer of Skye Bioscience, Inc., a Nevada corporation (the “Company”), the Company provided writ...
24 Aug 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
19 Aug 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
14 Aug 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +5 more
23 Jun 2026	8-K: Other Events
29 May 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
15 May 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
03 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
19 Mar 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
10 Mar 2026	8-K: Results of Operations and Financial Condition
20 Feb 2026	8-K: Departure/Election of Directors or Officers; Compensation
02 Feb 2026	8-K: Regulation FD Disclosure; Other Events
23 Dec 2025	8-K: Entry into a Material Definitive Agreement
10 Nov 2025	8-K: Results of Operations and Financial Condition
06 Oct 2025	8-K: Regulation FD Disclosure
07 Aug 2025	8-K: Results of Operations and Financial Condition
11 Jun 2025	8-K: Changes in Registrant's Certifying Accountant; Submission of Matters to a Vote of Security Holders
08 May 2025	8-K: Results of Operations and Financial Condition
20 Mar 2025	8-K: Results of Operations and Financial Condition
26 Feb 2025	8-K: Departure/Election of Directors or Officers; Compensation

Comments